EP300 and diffuse large B-cell lymphoma: CREBBP (CREB-binding protein; ~11%) and EP300 (E1A binding protein 300; ~6%) are genetically altered in ~17% of DLBCL cases, usually in a mutually exclusive fashion due to their high structural and functional homology (although CREBBP mutations are more frequent)73.